R. Munteanu, “5-Azacytidine treatment inhibits the development of lung cancer models via epigenetic reprogramming and activation of cellular pathways with anti-tumor activity”, Medicine and Pharmacy Reports, vol. 97, no. 4, pp. 488-506, Sep. 2024.